New Delhi, Jun 18 (PTI) A delegation from the Indian Pharmacopoeia Commission (IPC) under the Union health ministry represented India at the 16th International Meeting of World Pharmacopoeias (IMWP) and the accompanying stakeholders’ meeting held in Brasilia, Brazil from June 15 to 17.
Discussions during the meeting reaffirmed that the standards of the Indian Pharmacopoeias are comparable with leading international pharmacopoeias, it said.
The pharmacopoeias are official compendia of quality standards of the drugs being imported, manufactured for sale, stocked or exhibited for sale or distributed in a country. The pharmacopoeial monographs prescribe standards to ensure the identity, purity and strength of the given drugs through botanical identification, various physico-chemical parameters and the like.
The meeting, coordinated by the World Health Organization (WHO), brought together representatives from leading pharmacopoeias worldwide, including the Brazilian Pharmacopoeia, European Pharmacopoeia, Indian Pharmacopoeia (India), Japanese Pharmacopoeia (Japan), Mexican Pharmacopoeia, Russian Pharmacopoeia, British Pharmacopoeia, United States Pharmacopoeia and The International Pharmacopoeia of WHO among others.
In the meeting, Secretary-cum-Scientific Director Dr V Kalaiselvan presented key updates on the Indian Pharmacopoeia, highlighting recent advancements in pharmacopoeial standards, modernisation initiatives and India’s contributions towards global harmonisation of medicine quality standards, a health ministry statement said.
India was also recognised for its leadership in developing and establishing quality standards for anti-tuberculosis medicines, anti-cancer therapeutics, blood and blood products, medicines used in the management of anaemia and other complex pharmaceutical molecules, reflecting the country’s growing scientific, regulatory and pharmacopoeial capabilities, it said.
The Indian delegation actively contributed to discussions on modern microbiological methods, pharmacopoeial convergence and environmental sustainability in pharmaceutical standards.
At the stakeholders’ meeting, Dr Kalaiselvan, showcased India’s role in strengthening public health through science-based standards and regulatory support, while emphasising the importance of international cooperation in ensuring the quality, safety and efficacy of medicines worldwide.
India’s participation at the 16th IMWP further strengthened collaboration with international pharmacopoeias and reaffirmed the country’s growing leadership in shaping global pharmaceutical quality standards for the benefit of patients worldwide, the statement said. PTI PLB KSS KSS
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.